Discussing outcome in Tourette syndrome.

Clinical course of Tourette syndrome. J Psychosom Res (2009) 1.74

Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J Comp Neurol (2009) 1.04

Tic-related activity restriction as a predictor of emotional functioning and quality of life. Compr Psychiatry (2013) 0.81

Provisional Tic Disorder: What to tell parents when their child first starts ticcing. F1000Res (2016) 0.78

Clerodendrum inerme Leaf Extract Alleviates Animal Behaviors, Hyperlocomotion, and Prepulse Inhibition Disruptions, Mimicking Tourette Syndrome and Schizophrenia. Evid Based Complement Alternat Med (2012) 0.75

Hispidulin alleviated methamphetamine-induced hyperlocomotion by acting at α6 subunit-containing GABAA receptors in the cerebellum. Psychopharmacology (Berl) (2016) 0.75

Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med (2006) 2.62

Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science (2005) 8.20

L-histidine decarboxylase and Tourette's syndrome. N Engl J Med (2010) 2.92

Validity of the behavior rating inventory of executive function in children with ADHD and/or Tourette syndrome. Arch Clin Neuropsychol (2002) 1.69

Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68

Maternal antibrain antibodies in autism. Brain Behav Immun (2006) 1.62

A novel presentation of DYT 16: acute onset in infancy and association with MRI abnormalities. Mov Disord (2013) 1.58

Neuropsychological function in children with primary complex motor stereotypies. Dev Med Child Neurol (2014) 1.42

Trichotillomania (hair pulling disorder), skin picking disorder, and stereotypic movement disorder: toward DSM-V. Depress Anxiety (2010) 1.39

Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38

Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord (2004) 1.32

Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology (2007) 1.30

Effects of IQ on executive function measures in children with ADHD. Child Neuropsychol (2002) 1.23

Repetitive arm and hand movements (complex motor stereotypies) in children. J Pediatr (2004) 1.20

Nonautistic motor stereotypies: clinical features and longitudinal follow-up. Pediatr Neurol (2008) 1.15

Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry (2010) 1.15

MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res (2002) 1.11

Tic disorders: neural circuits, neurochemistry, and neuroimmunology. J Child Neurol (2006) 1.05

Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry (2012) 1.04

Neurobiology of tourette syndrome: current status and need for further investigation. J Neurosci (2011) 1.02

Large Genomic Deletions in CACNA1A Cause Episodic Ataxia Type 2. Front Neurol (2011) 0.98

Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis. J Neurol Sci (2007) 0.95

Behavioral therapy for treatment of stereotypic movements in nonautistic children. J Child Neurol (2006) 0.95

Frontal white matter reductions in healthy males with complex stereotypies. Pediatr Neurol (2005) 0.94

Pediatric movement disorders: an update. Curr Opin Neurol (2008) 0.94

Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci (2008) 0.94

Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome. Pediatr Neurol (2003) 0.94

Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet (2007) 0.94

Neuropsychiatric effects of guanfacine in children with mild tourette syndrome: a pilot study. Clin Neuropharmacol (2002) 0.93

Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol (2009) 0.92

Antineuronal antibodies in OCD: comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J Neuroimmunol (2009) 0.91

Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90

Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum. J Neurol Sci (2004) 0.87

A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome. Clin Neuropharmacol (2014) 0.85

Absent movement-related cortical potentials in children with primary motor stereotypies. Mov Disord (2013) 0.84

Childhood serum anti-fetal brain antibodies do not predict autism. Pediatr Neurol (2009) 0.83

Restless legs syndrome: association with streptococcal or mycoplasma infection. Pediatr Neurol (2004) 0.81

Microarray analysis in Tourette syndrome postmortem putamen. J Neurol Sci (2004) 0.81

Paroxysmal kinesigenic dyskinesias and pseudohypo-parathyroidism type Ib. Pediatr Neurol (2010) 0.81

A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord (2007) 0.80

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Psychiatr Genet (2006) 0.76

Medullary cistern choroid plexus papilloma. Childs Nerv Syst (2010) 0.76

Tourette syndrome: diagnosis, strategies, therapies, pathogenesis, and future research directions. J Child Neurol (2006) 0.76

[PANDAS--Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection: is it a specific clinical disorder?]. Rev Bras Psiquiatr (2005) 0.75

Methodologic factors affect the measurement of anti-basal ganglia antibodies. Ann Clin Lab Sci (2005) 0.75